Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth.
Here’s Why Conestoga Capital Advisors Sold Proto Labs Inc. (PRLB)
Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth’ Investor Letter – a copy of which can be downloaded here. A net return of 31% was recorded by Conestoga’s Small Cap Growth fund and 19.72% return by its SMid Cap Growth Fund for the the end year 2020. Both performed below their Russell 2000 Growth and Russell 2500 Growth benchmarks that delivered a 34.63% and 25.89% return respectively. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Conestoga Capital Advisors, in their Q4 2020 investor letter, emphasized that they sold their position in Proto Labs, Inc. (NYSE: PRLB) last year. Proto Labs, Inc. is a Minnesota-based digital manufacturing company that offers low-volume 3D printed custom parts for prototyping purposes. It currently has a $3.6 billion market capitalization. Si
Press release content from Business Wire. The AP news staff was not involved in its creation.
Simulations Plus Enters Agreement with Distributor in China
February 2, 2021 GMT
LANCASTER, Calif. (BUSINESS WIRE) Feb 2, 2021
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has entered into a distribution agreement with Mosim, one of China’s leading biopharmaceutical services companies, to distribute MonolixSuite™, the Lixoft division’s pharmacokinetic/pharmacodynamic (PK/PD) modeling platform, in China.
ADVERTISEMENT
Founded in 2015, Mosim was the first clinical contract research organization (CRO) providing clinical pharmacology services in China. During the last 5 years, by expanding its clinical operation team with a focus on clinical pharmacology studies, Mosim has become a full service clinical CRO. With a staff of over 100
Press release content from Business Wire. The AP news staff was not involved in its creation.
Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics
January 14, 2021 GMT
LANCASTER, Calif. (BUSINESS WIRE) Jan 14, 2021
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that its Cognigen division has awarded a grant to the Department of Pharmacology and Therapeutics at Makerere University in Kampala, Uganda, the country’s largest and oldest institution of higher learning, to fund upgraded internet capabilities, ensuring access to Cognigen’s KIWI TM platform. Access to this web-based knowledge-sharing platform will accelerate the University’s pharmaceutical research efforts and quantitative approaches, including modeling and simulation.
First quarter revenue of $10.7 million, reflecting 14% year-over-year growthBoard of Directors announces quarterly dividend of $0.06 per shareLANCASTER, Calif. (BUSINESS WIRE) Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemic.